Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
West Michigan Clinical Research Center
1793
mi
from 98109
Wyoming, MI
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
West Michigan Clinical Research Center
1793
mi
from 98109
Wyoming, MI
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
ActivMed Practices & Research, Inc.
2477
mi
from 98109
Portsmouth, NH
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
ActivMed Practices & Research, Inc.
2477
mi
from 98109
Portsmouth, NH
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Celiac Disease Center at Columbia University
2400
mi
from 98109
New York, NY
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Celiac Disease Center at Columbia University
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
PMG Research of Piedmont Healthcare
2257
mi
from 98109
Statesville, NC
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
PMG Research of Piedmont Healthcare
2257
mi
from 98109
Statesville, NC
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Great Lakes Gastroenterology Research
2032
mi
from 98109
Mentor, OH
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Great Lakes Gastroenterology Research
2032
mi
from 98109
Mentor, OH
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Hospitals - Center City Campus
mi
from 98109
Philadelphia, PA
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospitals - Center City Campus
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
2486
mi
from 98109
Warwick, RI
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
2486
mi
from 98109
Warwick, RI
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research
2426
mi
from 98109
Mount Pleasant, SC
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research
2426
mi
from 98109
Mount Pleasant, SC
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Digestive Health Research
1978
mi
from 98109
Hermitage, TN
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Digestive Health Research
1978
mi
from 98109
Hermitage, TN
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Texas Digestive Disease Consultants
1659
mi
from 98109
Southlake, TX
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Texas Digestive Disease Consultants
1659
mi
from 98109
Southlake, TX
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Advanced Research Institute
677
mi
from 98109
South Ogden, UT
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Advanced Research Institute
677
mi
from 98109
South Ogden, UT
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
Allegiance Research Specialists
1682
mi
from 98109
Wauwatosa, WI
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
Allegiance Research Specialists
1682
mi
from 98109
Wauwatosa, WI
Click here to add this to my saved trials
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated:  12/31/1969
The Wesley Hospital - The Wesley Research Institute
mi
from 98109
Auchenflower,
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study in HLA-DQ2.5+ Adults With Celiac Disease to Assess the Effect of Nexvax2 on Symptoms After Masked Gluten Food Challenge
Status: Enrolling
Updated: 12/31/1969
The Wesley Hospital - The Wesley Research Institute
mi
from 98109
Auchenflower,
Click here to add this to my saved trials
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
Televideo Exercise and Nutrition Program for Kidney Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated:  12/31/1969
Grady Health System
2178
mi
from 98109
Atlanta, GA
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated: 12/31/1969
Grady Health System
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated:  12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
Water Versus Saline as Irrigation Fluid for Ureteroscopy
The Effects of Water Versus Saline on Absorption Rates and Visualization During Ureteroscopy
Status: Enrolling
Updated: 12/31/1969
Emory University
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Treatment Targets for Chronic Hypertension in Pregnancy
Treatment Targets for Chronic Hypertension in Pregnancy
Status: Enrolling
Updated:  4/26/2006
The New York PresbyterianHospital-Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
Treatment Targets for Chronic Hypertension in Pregnancy
Treatment Targets for Chronic Hypertension in Pregnancy
Status: Enrolling
Updated: 4/26/2006
The New York PresbyterianHospital-Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
Renal Blood Flow Measurement With PET
Status: Enrolling
Updated:  9/2/2008
University of Wisconsin-Madison
1616
mi
from 98109
Madison, WI
Renal Blood Flow Measurement With Positron Emission Tomography (PET)
Renal Blood Flow Measurement With PET
Status: Enrolling
Updated: 9/2/2008
University of Wisconsin-Madison
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
Status: Enrolling
Updated:  8/26/2010
Urology Center of Charleston
2127
mi
from 98109
Charleston, WV
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
Status: Enrolling
Updated: 8/26/2010
Urology Center of Charleston
2127
mi
from 98109
Charleston, WV
Click here to add this to my saved trials
Vancomycin-Associated Nephrotoxicity
Occurrence and Economic Impact of Nephrotoxicity Associated With Vancomycin Exposure
Status: Enrolling
Updated:  10/8/2010
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Vancomycin-Associated Nephrotoxicity
Occurrence and Economic Impact of Nephrotoxicity Associated With Vancomycin Exposure
Status: Enrolling
Updated: 10/8/2010
Univ of Rochester Medical Center
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery
Minimally Invasive Urologic Surgery Clip Evaluation: Can We Improve Our Surgical Technique, Reduce Costs and Waste With the Aesculap U-clip Versus the Tele-Flex Hemolock Clip?
Status: Enrolling
Updated:  10/18/2010
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery
Minimally Invasive Urologic Surgery Clip Evaluation: Can We Improve Our Surgical Technique, Reduce Costs and Waste With the Aesculap U-clip Versus the Tele-Flex Hemolock Clip?
Status: Enrolling
Updated: 10/18/2010
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Long Term Fructose
Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance: a Double-blind, Randomized Crossover Study
Status: Enrolling
Updated:  1/31/2011
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Long Term Fructose
Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance: a Double-blind, Randomized Crossover Study
Status: Enrolling
Updated: 1/31/2011
University of Iowa Hospitals and Clinics
1557
mi
from 98109
Iowa City, IA
Click here to add this to my saved trials
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
Correlation of Hydronephrosis on Point of Care Ultrasound With CT Finding in Patients With Expected Renal Colic
Status: Enrolling
Updated:  5/5/2011
Yale University, Emergency Department
2432
mi
from 98109
New Haven, CT
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
Correlation of Hydronephrosis on Point of Care Ultrasound With CT Finding in Patients With Expected Renal Colic
Status: Enrolling
Updated: 5/5/2011
Yale University, Emergency Department
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Status: Enrolling
Updated:  6/1/2011
Loma Linda University Medical Center
974
mi
from 98109
Loma Linda, CA
Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Status: Enrolling
Updated: 6/1/2011
Loma Linda University Medical Center
974
mi
from 98109
Loma Linda, CA
Click here to add this to my saved trials
Study to Determine if There Are Specific Clinical Factors to Determine Stent Encrustation
Study to Determine if There Are Specific Clinical Factors to Determine Stent Encrustation
Status: Enrolling
Updated:  9/1/2011
University of California, Irvine Medical Center
984
mi
from 98109
Orange, CA
Study to Determine if There Are Specific Clinical Factors to Determine Stent Encrustation
Study to Determine if There Are Specific Clinical Factors to Determine Stent Encrustation
Status: Enrolling
Updated: 9/1/2011
University of California, Irvine Medical Center
984
mi
from 98109
Orange, CA
Click here to add this to my saved trials
Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
Effect of Oral Galactose on the Level of Focal Sclerosis Permeability Factor and Proteinuria in Children With Steroid Resistant Nephrotic Syndrome: A Pilot Study
Status: Enrolling
Updated:  1/16/2012
Childrens National Medical Center
2322
mi
from 98109
Washington,
Oral Galactose in Children With Steroid Resistant Nephrotic Syndrome
Effect of Oral Galactose on the Level of Focal Sclerosis Permeability Factor and Proteinuria in Children With Steroid Resistant Nephrotic Syndrome: A Pilot Study
Status: Enrolling
Updated: 1/16/2012
Childrens National Medical Center
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Prospective Pediatric Pyeloplasty Robotic Surgical Database
Prospective Pediatric Pyeloplasty Robotic Surgical Database
Status: Enrolling
Updated:  2/9/2012
Connecticut Children's Medical Center
2429
mi
from 98109
Hartford, CT
Prospective Pediatric Pyeloplasty Robotic Surgical Database
Prospective Pediatric Pyeloplasty Robotic Surgical Database
Status: Enrolling
Updated: 2/9/2012
Connecticut Children's Medical Center
2429
mi
from 98109
Hartford, CT
Click here to add this to my saved trials
Alfuzosin for Medical Expulsion Therapy of Ureteral Stones
Evaluation of Alfuzosin as Medical Expulsion Therapy for Ureteral Stones
Status: Enrolling
Updated:  4/25/2012
Naval Medical Center - San Diego
1077
mi
from 98109
San Diego, CA
Alfuzosin for Medical Expulsion Therapy of Ureteral Stones
Evaluation of Alfuzosin as Medical Expulsion Therapy for Ureteral Stones
Status: Enrolling
Updated: 4/25/2012
Naval Medical Center - San Diego
1077
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy.
Status: Enrolling
Updated:  7/10/2012
University of Texas Hlth Sci Ctr San Ant
1780
mi
from 98109
San Antonio, TX
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy.
Status: Enrolling
Updated: 7/10/2012
University of Texas Hlth Sci Ctr San Ant
1780
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Study of RE-021 in Patients With Focal Segmental Glomerulosclerosis
A Study of RE-021 in Patients With Focal Segmental Glomerulosclerosis
Status: Enrolling
Updated:  7/24/2012
NYU School of Medicine - Langone Medical Center
2401
mi
from 98109
New York, NY
A Study of RE-021 in Patients With Focal Segmental Glomerulosclerosis
A Study of RE-021 in Patients With Focal Segmental Glomerulosclerosis
Status: Enrolling
Updated: 7/24/2012
NYU School of Medicine - Langone Medical Center
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Status: Enrolling
Updated:  8/1/2012
Columbia University Medical Center, Division of Nephrology, Glomerular Center
2401
mi
from 98109
New York, NY
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Status: Enrolling
Updated: 8/1/2012
Columbia University Medical Center, Division of Nephrology, Glomerular Center
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Urinary Biomarkers of the Progression of Alport Kidney Disease
Urinary Biomarkers of the Progression of Alport Kidney Disease
Status: Enrolling
Updated:  10/10/2012
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Urinary Biomarkers of the Progression of Alport Kidney Disease
Urinary Biomarkers of the Progression of Alport Kidney Disease
Status: Enrolling
Updated: 10/10/2012
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy
A Dose-Finding Pilot Study of ACTH on the Serum Lipoprotein Profile and Proteinuria in Patients With Idiopathic Membranous Nephropathy (MN)
Status: Enrolling
Updated:  11/6/2012
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy
A Dose-Finding Pilot Study of ACTH on the Serum Lipoprotein Profile and Proteinuria in Patients With Idiopathic Membranous Nephropathy (MN)
Status: Enrolling
Updated: 11/6/2012
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
Dose Escalation Study Of I.V. And Intra-Aortic N-Acetylcysteine For The Prevention Of Contrast Induced Nephropathy In Patients With Stage 3 Renal Failure Undergoing Contrast Imaging Studies: A Phase I Trial
Status: Enrolling
Updated:  11/28/2012
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
Dose Escalation Study Of I.V. And Intra-Aortic N-Acetylcysteine For The Prevention Of Contrast Induced Nephropathy In Patients With Stage 3 Renal Failure Undergoing Contrast Imaging Studies: A Phase I Trial
Status: Enrolling
Updated: 11/28/2012
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly Females
Recovery Following Desflurane vs Sevoflurane for Outpatient Urologic Surgery in Elderly Females
Status: Enrolling
Updated:  12/10/2012
Hahnemann University Hospital
2373
mi
from 98109
Philadelphia, PA
Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly Females
Recovery Following Desflurane vs Sevoflurane for Outpatient Urologic Surgery in Elderly Females
Status: Enrolling
Updated: 12/10/2012
Hahnemann University Hospital
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Status: Enrolling
Updated:  12/11/2012
Stanford University School of Medicine
705
mi
from 98109
Stanford, CA
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Status: Enrolling
Updated: 12/11/2012
Stanford University School of Medicine
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
University of Miami
2730
mi
from 98109
Miami, FL
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
University of Miami
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Emory University
2178
mi
from 98109
Atlanta, GA
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Emory University
2178
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
University of Kansas
1500
mi
from 98109
Kansas City, KA
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
University of Kansas
1500
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Boston Children's Hospital
2485
mi
from 98109
Boston, MA
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Boston Children's Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Mayo Clinic Rochester
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Children's Mercy Hospital
1504
mi
from 98109
Kansas City, MO
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Children's Mercy Hospital
1504
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Cardinal Glennon Children's Medical Center
1718
mi
from 98109
St. Louis, MO
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Cardinal Glennon Children's Medical Center
1718
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Steven and Alexandra Cohen Children's Medical Center of New York
2401
mi
from 98109
New York, NY
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Steven and Alexandra Cohen Children's Medical Center of New York
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Columbia University Medical Center
2401
mi
from 98109
New York, NY
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Columbia University Medical Center
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
New York University Langone Medical Center
2402
mi
from 98109
New York, NY
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
New York University Langone Medical Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Carolinas Medical Center
2281
mi
from 98109
Charlotte, NC
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Carolinas Medical Center
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated:  12/12/2012
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Novel Therapies for Resistant FSGS (FONT II): Phase II Clinical Trial
Novel Therapies for Resistant FSGS
Status: Enrolling
Updated: 12/12/2012
Cincinnati Children's Hospital Medical Center
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials